Saara Laukkanen

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Transcription Factor

Acute Lymphoblastic Leukemia

Top Venues

Leukemia & lymphoma

University of Tampere

University of Tampere (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tampere

Finland

PhD student :: School of medicine

Education History

University of Tampere

Finland

MSC :: BioMediTech

Publications

Saara Laukkanen, Alexandra Veloso, Chuan Yan, Laura Oksa, Eric J Alpert, Daniel Do, Noora Hyvärinen, Karin McCarthy, Abhinav Adhikari, Qiqi Yang, Sowmya Iyer, Sara P Garcia, Annukka Pello, Tanja Ruokoranta, Sanni Moisio, Sadiksha Adhikari, Jeffrey A Yoder, Kayleigh Gallagher, Lauren Whelton, James R Allen, Alexander H Jin, Siebe Loontiens, Merja Heinäniemi, Michelle Kelliher, Caroline A Heckman, Olli Lohi, David M Langenau
Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia. Blood 140 (17) (2022)
Laura Oksa, Artturi Mäkinen, Atte Nikkilä, Noora Hyvärinen, Saara Laukkanen, Anne Rokka, Pekka Haapaniemi, Masafumi Seki, Junko Takita, Otto Kauko, Merja Heinäniemi, Olli Lohi
Arginine Methyltransferase PRMT7 Deregulates Expression of RUNX1 Target Genes in T-Cell Acute Lymphoblastic Leukemia. Cancers 14 (9) (2022)
Saara Laukkanen, Laura Oksa, Atte Nikkilä, Mari Lahnalampi, Mataleena Parikka, Masafumi Seki, Junko Takita, Sofie Degerman, Charles E de Bock, Merja Heinäniemi, Olli Lohi
SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome. Leukemia & lymphoma 61 (13) (2020)